Experimental investigation of herpes simplex virus latency

Clinical Microbiology Reviews

Volumn 10, Issue 3, 1997, Pages 419-443

  Wagner, Edward K ^a   Bloom, David C ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; VIRUS DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; AUTONOMIC NERVE; CELL CULTURE; CELL NUCLEUS; CLINICAL FEATURE; CORNEA CELL; CYTOPATHOLOGY; FOOT PAD; GENE EXPRESSION; GUINEA PIG; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS; HUMAN; IMMUNE SYSTEM; IN SITU HYBRIDIZATION; MOUSE; NERVE CELL; NONHUMAN; PHENOTYPE; RABBIT; REVIEW; SENSORY NERVE CELL; SPINAL GANGLION; STRAIN DIFFERENCE; TRANSCRIPTION INITIATION; TRIGEMINUS GANGLION; VARICELLA ZOSTER VIRUS; VIRUS CLASSIFICATION; VIRUS GENE; VIRUS GENOME; VIRUS INFECTION; VIRUS LATENCY; VIRUS REACTIVATION; VIRUS REPLICATION;

ANIMALIA; CAVIA PORCELLUS; DNA VIRUSES; HERPES; HUMAN HERPESVIRUS 3; ORYCTOLAGUS CUNICULUS; SIMPLEXVIRUS; SUS SCROFA;

EID: 0030832408     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/cmr.10.3.419     Document Type: Review

References (332)

1. Agut, H., N. Dupin, J. T. Aubin, and J. M. Huraux. 1996. L'herpesvirus humain 8. Transfus. Clin. Biol. 3:51-56.
2. Arthur, J., S. Efstathiou, and A. Simmons. 1993. Intranuclear foci containing low abundance herpes simplex virus latency-associated transcripts visualized by non-isotopic in situ hybridization. J. Gen. Virol. 74:1363-1370.
3. Baringer, J. R. 1974. Recovery of herpes simplex virus from human sacral ganglions. N. Engl. J. Med. 291:828-830.
4. Baringer, J. R., and P. Pisani. 1994. Herpes simplex virus genomes in human nervous system tissue analyzed by polymerase chain reaction. Ann. Neurol. 36:823-829.
5. Baringer, J. R., and P. Swoveland. 1973. Recovery of herpes-simplex virus from human trigeminal ganglions. N. Engl. J. Med. 288:648-650.
6. Bastian, F. O., A. S. Rabson, C. L. Yee, and T. S. Tralka. 1972. Herpesvirus hominis: isolation from human trigeminal ganglion. Science 178:306-307.
7. Batchelor, A. H., and P. O'Hare. 1990. Regulation and cell-type-specific activity of a promoter located upstream of the latency-associated transcript of herpes simplex virus type 1. J. Virol. 64:3269-3279.
8. Batchelor, A. H., and P. O'Hare. 1992. Localization of cis-acting sequence requirements in the promoter of the latency-associated transcript of herpes simplex virus type 1 required for cell-type-specific activity. J. Virol. 66:3573-3582.
9. Batchelor, A. H., K. W. Wilcox, and P. O'Hare. 1994. Binding and repression of the latency-associated promoter of herpes simplex virus by the immediate early 175K protein. J. Gen. Virol. 75:753-767.
10. Baxi, M. K., S. Efstathiou, G. Lawrence, J. M. Whalley, J. D. Slater, and H. J. Field. 1995. The detection of latency-associated transcripts of equine herpesvirus 1 in ganglionic neurons. J. Gen. Virol. 76:3113-3118.
11. Benedetti, J., L. Corey, and R. Ashley. 1994. Recurrence rates in genital herpes after symptomatic first-episode infection. Ann. Intern. Med. 121: 847-854.
12. Bergstrom, T., and E. Lycke. 1990. Neuroinvasion by herpes simplex virus. An in vitro model for characterization of neurovirulent strains. J. Gen. Virol. 71:405-410.
13. Berman, E. J., and J. M. Hill. 1985. Spontaneous ocular shedding of HSV-1 in latently infected rabbits. Invest. Ophthalmol. Visual Sci. 26:587-590.
14. Block, T. M., S. Deshmane, J. Masonis, J. Maggioncalda, T. Valyi-Nagi, and N. W. Fraser. 1993. An HSV LAT null mutant reactivates slowly from latent infection and makes small plaques on CV-1 monolayers. Virology 192:618-630.
15. Block, T. M., J. G. Spivack, I. Steiner, S. Deshmane, M. T. McIntosh, R. P. Lirette, and N. W. Fraser. 1990. A herpes simplex virus type 1 latency-associated transcript mutant reactivates with normal kinetics from latent infection. J. Virol. 64:3417-3426.
16. Bloom, D. C., G. B. Devi-Rao, J. M. Hill, J. G. Stevens, and E. K. Wagner. 1994. Molecular analysis of herpes simplex virus type 1 during epinephrine-induced reactivation of latently infected rabbits in vivo. J. Virol. 68:1283-1292.
17. Bloom, D. C., J. M. Hill, G. Devi-Rao, E. K. Wagner, L. T. Feldman, and J. G. Stevens. 1996. A 348-base-pair region in the latency-associated transcript facilitates herpes simplex virus type 1 reactivation. J. Virol. 70:2449-2459.
18. Bloom, D. C., and J. G. Stevens. 1994. Neuron-specific restriction of a herpes simplex virus recombinant maps to the UL5 gene. J. Virol. 68:3761-3772.
19. Bloom, D. C., J. G. Stevens, J. M. Hill, and R. K. Tran. Mutagenesis of a cAMP response element within the latency-associated promoter of HSV-1 reduces adrenergic reactivation. Virology, in press.
20. Bloom, D. C., E. K. Wagner, and J. M. Hill. 1997. Unpublished data.
21. Bohenzky, R. A., M. Lagunoff, B. Roizman, E. K. Wagner, and S. Silverstein. 1995. Two overlapping transcription units which extend across the L-S junction of herpes simplex virus type 1. J. Virol. 69:2889-2897.
22. Bolovan, C. A., N. M. Sawtell, and R. L. Thompson. 1994. ICP34.5 mutants of herpes simplex virus type 1 strain 17syn+ are attenuated for neurovirulence in mice and for replication in confluent primary mouse embryo cell cultures. J. Virol. 68:48-55.
23. Bourne, N., L. R. Stanberry, B. L. Connelly, J. Kurawadwala, S. E. Straus, and P. R. Krause. 1994. Quantity of latency-associated transcript produced by herpes simplex virus is not predictive of the frequency of experimental recurrent genital herpes. J. Infect. Dis. 169:1084-1087.
24. Brandt, C. R., R. Kinter, R. J. Visali, and A. M. Pumfery. 1994. Ribonucleotide reductase and the ocular virulence of herpes simplex virus type 1, p. 136-150. In Y. Becker and G. Darai (ed.), Pathogenicity of human herpesviruses due to specific pathogenicity genes. Springer-Verlag KG, Berlin, Germany.
25. Bratcher, D. F., C. J. Harrison, N. Bourne, L. R. Stanberry, and D. I. Bernstein. 1993. Effect of indomethacin on ultraviolet radiation-induced recurrent herpes simplex virus disease in guinea-pigs. J. Gen. Virol. 74: 1951-1954.
26. Brown, S. M., J. Harland, A. R. MacLean, J. Podlech, and J. B. Clements. 1994. Cell type and cell state determine differential in vitro growth of non-neurovirulent ICP34.5-negative herpes simplex virus types 1 and 2. J. Gen. Virol. 75:2367-2377.
27. Cabrera, C. V., C. Wohlenberg, H. Openshaw, M. Rey-Mendez, A. Puga, and A. L. Notkins. 1980. Herpes simplex virus DNA sequences in the CNS of latently infected mice. Nature 288:288-290.
28. Cantello, J. L., A. S. Anderson, and R. W. Morgan. 1994. Identification of latency-associated transcripts that map antisense to the ICP4 homolog gene of Marek's disease virus. J. Virol. 68:6280-6290.
29. Carter, K. L., and B. Roizman. 1996. The promoter and transcriptional unit of a novel herpes simplex virus 1 α gene are contained in, and encode a protein in frame with, the open reading frame of the α22 gene. J. Virol. 70:172-178.
30. Chen, X. W., M. C. Schmidt, W. F. Goins, and J. C. Glorioso. 1995. Two herpes simplex virus type 1 latency-active promoters differ in their contributions to latency-associated transcript expression during lytic and latent infections. J. Virol. 69:7899-7908.
31. Cheung, A. K. 1989. Detection of pseudorabies virus transcripts in trigeminal ganglia of latently infected swine. J. Virol. 63:2908-2913.
32. 134.5, a gene nonessential for growth in culture. Science 250:1262-1266.
33. Chou, J., and B. Roizman. 1992. The gamma-1 34.5 gene of herpes simplex virus 1 precludes neuroblastoma cells from triggering total shutoff of protein synthesis characteristic of programed cell death in neuronal cells. Proc. Natl. Acad. Sci. USA 89:3266-3270.
34. Clements, G. B., and J. H. Subak-Sharpe. 1988. Herpes simplex virus type 2 establishes latency in the mouse footpad. J. Gen. Virol. 69:375-383.
35. Clough, D. W., L. M. Kunkel, and R. L. Davidson. 1982. 5-Azacytidine-induced reactivation of a herpes simplex thymidine kinase gene. Science 216:70-73.
36. Cohrs, R. J., M. B. Barbour, R. Mahalingam, M. Wellish, and D. H. Gilden. 1995. Varicella-zoster virus (VZV) transcription during latency in human ganglia: prevalence of VZV gene 21 transcripts in latently infected human ganglia. J. Virol. 69:2674-2678.
37. Cohrs, R. J., K. Srock, M. B. Barbour, G. Owens, R. Mahalingam, M. E. Devlin, M. Wellish, and D. H. Gilden. 1994. Varicella-zoster virus (VZV) transcription during latency in human ganglia: construction of a cDNA library from latently infected human trigeminal ganglia and detection of a VZV transcript. J. Virol. 68:7900-7908.
38. Cone, R. W., A. C. Hobson, J. Palmer, M. Remington, and L. Corey. 1991. Extended duration of herpes simplex virus DNA in genital lesions detected by the polymerase chain reaction. J. Infect. Dis. 164:757-760.
39. Cook, M. L., and J. G. Stevens. 1973. Pathogenesis of herpetic neuritis and ganglionitis in mice: evidence for intra-axonal transport of infection. Infect. Immun. 7:272-288.
40. Cook, M. L., and J. G. Stevens. 1976. Latent herpetic infections following experimental viraemia. J. Gen. Virol. 31:75-80.
41. Cook, S. D., S. K. Batra, and S. M. Brown. 1987. Recovery of herpes simplex virus from the corneas of experimentally infected rabbits. J. Gen. Virol. 68:2013-2017.
42. Cook, S. D., J. M. Hill, C. Lynas, and N. J. Maitland. 1991. Latency-associated transcripts in corneas and ganglia of HSV-1 infected rabbits. Br. J. Ophthalmol. 75:644-648.
43. Corbellino, M., G. Bestetti, L. Poirel, J. T. Aubin, L. Brambilla, M. Pizzuto, M. Capra, E. Berti, M. Galli, and C. Parravicini. 1996. Is human herpesvirus type 8 fairly prevalent among healthy subjects in Italy? J. Infect. Dis. 174:668-669.
44. Corey, L. 1994. The current trend in genital herpes. Progress in prevention. Sex. Transm. Dis. 21:S38-S44.
45. Corey, L., A. Wald, and L. G. Davis. 1996. Subclinical shedding of HSV: its potential for reduction by antiviral therapy. Adv. Exp. Med. Biol. 394:11-16.
46. Croen, K. D., J. M. Ostrove, L. Dragovic, and S. E. Straus. 1991. Characterization of herpes simplex virus type 2 latency-associated transcription in human sacral ganglia and in cell culture. J. Infect. Dis. 163:23-28.
47. Croen, K. D., J. M. Ostrove, L. J. Dragovic, J. E. Smialek, and S. E. Straus. 1987. Latent herpes simplex virus in human trigeminal ganglia. Detection of an immediate early gene "anti-sense" transcript by in situ hybridization. N. Engl. J. Med. 317:1427-1432.
48. Croen, K. D., J. M. Ostrove, L. J. Dragovic, and S. E. Straus. 1988. Patterns of gene expression and sites of latency in human nerve ganglia are different for varicella-zoster and herpes simplex viruses. Proc. Natl. Acad. Sci. USA 85:9773-9777.
49. Davison, A. J. 1991. Varicella-zoster virus. J. Gen. Virol. 72:475-486.
50. Davison, A. J., and J. E. Scott. 1986. The complete DNA sequence of varicella-zoster virus. J. Gen. Virol. 67:1759-1816.
51. Deatly, A. M., J. G. Spivack, E. Lavi, and N. W. Fraser. 1987. RNA from an immediate early region of the type 1 herpes simplex virus genome is present in the trigeminal ganglia of latently infected mice. Proc. Natl. Acad. Sci. USA 84:3204-3208.
52. Deatly, A. M., J. G. Spivack, E. Lavi, D. R. O'Boyle, and N. W. Fraser. 1988. Latent herpes simplex virus type 1 transcripts in peripheral and central nervous system tissues of mice map to similar regions of the viral genome. J. Virol. 62:749-756.
53. de Bruyn Kops, A., and D. M. Knipe. 1988. Formation of DNA replication structures in herpes virus-infected cells requires a viral DNA binding protein. Cell 55:857-868.
54. Deshmane, S. L., and N. W. Fraser. 1989. During latency, herpes simplex virus type 1 DNA is associated with nucleosomes in a chromatin structure. J. Virol. 63:943-947.
55. Deshmane, S. L., M. Nicosia, T. Valyi-Nagy, L. T. Feldman, A. Dillner, and N. W. Fraser. 1993. An HSV-1 mutant lacking the LAT TATA element reactivates normally in explant cocultivation. Virology 196:868-872.
56. Devi-Rao, G. B., D. C. Bloom, J. G. Stevens, and E. K. Wagner. 1994. Herpes simplex virus type 1 DNA replication and gene expression during explant induced reactivation of latently infected murine sensory ganglia. J. Virol. 68:1271-1282.
57. Devi-Rao, G. B., S. A. Goodart, L. B. Hecht, R. Rochford, M. K. Rice, and E. K. Wagner. 1991. The relationship between polyadenylated and non-polyadenylated herpes simplex virus type 1 latency-associated transcripts. J. Virol. 65:2179-2190.
58. Di Luca, D., R. Dolcetti, B. Bigoni, A. Carbone, L. De Lellis, M. Boiocchi, and E. Cassai. 1996. Is human herpesvirus type 8 fairly prevalent among healthy subjects in Italy? J. Infect. Dis. 174:669-670.
59. Dobson, A. T., T. P. Margolis, F. Sedarati, J. G. Stevens, and L. T. Feldman. 1990. A latent, nonpathogenic HSV-1-derived vector stably expresses β-galactosidase in mouse neurons. Neuron 5:353-360.
60. Dobson, A. T., F. Sedarati, G. B. Devi-Rao, W. M. Flanagan, M. J. Farrell, J. G. Stevens, E. K. Wagner, and L. T. Feldman. 1989. Identification of the latency-associated transcript promoter by expression of rabbit beta-globin mRNA in mouse sensory nerve ganglia latently infected with a recombinant herpes simplex virus. J. Virol. 63:3844-3851.
61. Doerig, C., L. I. Pizer, and C. L. Wilcox. 1991. An antigen encoded by the latency-associated transcript in neuronal cell cultures latently infected with herpes simplex virus type 1. J. Virol. 65:2724-2727.
62. Doerig, C., L. I. Pizer, and C. L. Wilcox. 1991. Detection of the latency-associated transcript in neuronal cultures during the latent infection with herpes simplex virus type 1. Virology 183:423-426.
63. Dressler, G. R., D. L. Rock, and N. W. Fraser. 1987. Latent herpes simplex virus type 1 DNA is not extensively methylated in vivo. J. Gen. Virol. 68:1761-1765.
64. Drummond, C. W. E., R. P. Eglin, and M. M. Esiri. 1994. Herpes simplex virus encephalitis in a mouse model: PCR evidence for CNS latency following acute infection. J. Neurol. Sci. 127:159-163.
65. Dubin, G., N. O. Fishman, R. J. Eisenberg, G. H. Cohen, and H. M. Friedman. 1992. The role of herpes simplex virus glycoproteins in immune evasion. Curr. Top. Microbiol. Immunol. 179:111-120.
66. Dueland, A. N., T. Ranneberg-Nilsen, and M. Degré. 1995. Detection of latent varicella zoster virus DNA and human gene sequences in human trigeminal ganglia by in situ amplification combined with in situ hybridization. Arch. Virol. 140:2055-2066.
67. Ecob-Prince, M. S., K. Hassan, M. T. Denheen, and C. M. Preston. 1995. Expression of β-galactosidase in neurons of dorsal root ganglia which are latently infected with herpes simplex virus type 1. J. Gen. Virol. 76:1527-1532.
68. Ecob-Prince, M. S., F. J. Rixon, C. M. Preston, K. Hassan, and P. G. E. Kennedy. 1993. Reactivation in vivo and in vitro of herpes simplex virus from mouse dorsal root ganglia which contain different levels of latency-associated transcripts. J. Gen. Virol. 74:995-1002.
69. Efstathiou, S., A. C. Minson, H. J. Field, J. R. Anderson, and P. Wildy. 1986. Detection of herpes simplex virus-specific DNA sequences in latently infected mice and in humans. J. Virol. 57:446-455.
70. Everett, R. D. 1989. Construction and characterization of herpes simplex virus type 1 mutants with defined lesions in immediate early gene 1. J. Gen. Virol. 70:1185-1202.
71. Everett, R. D., C. M. Preston, and N. D. Stow. 1991. Functional and genetic analysis of the role of Vmw110 in herpes simplex virus replication, p. 49-76. In E. K. Wagner (ed.), Herpesvirus transcription and its regulation. CRC Press, Inc., Boca Raton, Fla.
72. Fareed, M. U., and J. G. Spivack. 1994. Two open reading frames (ORF1 and ORF2) within the 2.0-kilobase latency-associated transcript of herpes simplex virus type 1 are not essential for reactivation from latency. J. Virol. 68:8071-8081.
73. Farrell, M. J., A. T. Dobson, and L. T. Feldman. 1991. Herpes simplex virus latency-associated transcript is a stable intron. Proc. Natl. Acad. Sci. USA 88:790-794.
74. Farrell, M. J., J. M. Hill, T. P. Margolis, J. G. Stevens, E. K. Wagner, and L. T. Feldman. 1993. The herpes simplex virus type 1 reactivation function lies outside the latency-associated transcript open reading frame ORF-2. J. Virol. 67:3653-3655.
75. Farrell, P. J. 1995. Epstein-Barr virus immortalizing genes. Trends. Microbiol. 3:105-109.
76. Fawl, R. L., R. M. Gesser, T. Valyi-Nagy, and N. W. Fraser. Reactivation of herpes simplex virus from latently infected mice after administration of cadmium is mouse strain specific. J. Gen. Virol., in press.
77. Fawl, R. L., and B. Roizman. 1993. Induction of reactivation of herpes simplex virus in murine sensory ganglia in vivo by cadmium. J. Virol. 67:7025-7031.
78. Feduchi, E., and L. Carrasco. 1991. Mechanism of inhibition of HSV-1 replication by tumor necrosis factor and interferon gamma. Virology 180: 822-825.
79. Felser, J. M., S. E. Straus, and J. M. Ostrove. 1987. Varicella-zoster virus complements herpes simplex virus type 1 temperature-sensitive mutants. J. Virol. 61:225-228.
80. Field, H. J., and P. Wildy. 1978. The pathogenicity of thymidine kinase-deficient mutants of herpes simplex virus in mice. J. Hyg. 81:267-277.
81. Fowler, S. L., C. J. Harrison, M. G. Meyers, and L. R. Stanberry. 1992. Outcome of herpes simplex virus type 2 infection in guinea pigs. J. Med. Virol. 36:303-308.
82. Frazier, D. P., D. Cox, E. M. Godshalk, and P. A. Schaffer. 1996. The herpes simplex virus type 1 latency-associated transcript promoter is activated through Ras and Raf by nerve growth factor and sodium butyrate in PC12 cells. J. Virol. 70:7424-7432.
83. Frazier, D. P., D. Cox, E. M. Godshalk, and P. A. Schaffer. 1996. Identification of cis-acting sequences in the promoter of the herpes simplex virus type 1 latency-associated transcripts required for activation by nerve growth factor and sodium butyrate in PC12 cells. J. Virol. 70:7433-7444.
84. Frenkel, N., and L. S. Wyatt. 1992. HHV-6 and HHV-7 as exogenous agents in human lymphocytes. Dev. Biol. Stand. 76:259-265.
85. Friedman, H. M., L. Y. Wang, N. O. Fishman, J. D. Lambris, R. J. Eisenberg, G. H. Cohen, and J. Lubinski. 1996. Immune evasion properties of herpes simplex virus type 1 glycoprotein gC. J. Virol. 70:4253-4260.
86. Gelven, P. L., K. K. Gruber, F. K. Swiger, S. J. Cina, and R. A. Harley. 1996. Fatal disseminated herpes simplex in pregnancy with maternal and neonatal death. South. Med. J. 89:732-734.
87. Gerdes, J. C., and D. S. Smith. 1983. Recurrence phenotypes and establishment of latency following rabbit keratitis produced by multiple herpes simplex virus strains. J. Gen. Virol. 64:2441-2454.
88. Gesser, R. M., and S. C. Koo. 1996. Oral inoculation with herpes simplex virus type 1 infects enteric neurons and mucosal nerve fibers within the gastrointestinal tract in mice. J. Virol. 70:4097-4102.
89. Gesser, R. M., T. Valyi-Nagy, S. M. Altschuler, and N. W. Fraser. 1994. Oral-oesophageal inoculation of mice with herpes simplex virus type 1 causes latent infection of the vagal sensory ganglia (nodose ganglia). J. Gen. Virol. 75:2379-2386.
90. Gesser, R. M., T. Valyi-Nagy, and N. W. Fraser. 1994. Restricted herpes simplex virus type 1 gene expression within sensory neurons in the absence of functional B and T lymphocytes. Virology 200:791-795.
91. Gilden, D. H. 1993. Herpesvirus infections of the central nervous system, p. 76-102. In J. B. Martin and K. L. Tyler (ed.), Infectious diseases of the nervous system. F.A. Davis, New York, N.Y.
92. Gilden, D. H., R. Mahalingam, A. N. Dueland, and R. Cohrs. 1992. Herpes zoster: pathogenesis and latency. Prog. Med. Virol. 39:19-75.
93. Gilden, D. H., Y. Rozenman, R. Murray, M. Devlin, and A. Vafai. 1987. Detection of varicella-zoster virus nucleic acid in neurons of normal human thoracic ganglia. Ann. Neurol. 22:377-380.
94. L flanking repeats. J. Virol. 68:2239-2252.
95. Goodpasture, E. W. 1929. Herpetic infections with special reference to involvement of the nervous system. Medicine (Baltimore) 7:223-243.
96. Gordon, Y. J. 1990. Pathogenesis and latency of herpes simplex virus type 1 (HSV-1): an ophthalmologist's view of the eye as a model for the study of the virus-host relationship. Adv. Exp. Med. Biol. 278:205-209.
97. Gordon, Y. J., E. Romanowski, T. Araullo-Cruz, and J. L. C. McKnight. 1991. HSV-1 corneal latency. Invest. Ophthalmol. Visual Sci. 32:663-665.
98. Green, M. T., R. J. Courtney, and E. C. Dunkel. 1981. Detection of an immediate-early herpes simplex virus type 1 polypeptide in trigeminal ganglia from latently infected animals. Infect. Immun. 34:987-992.
99. Green, M. T., E. C. Dunkel, and R. J. Courtney. 1984. Detection of herpes simplex virus induced polypeptides in rabbit trigeminal ganglia. Invest. Ophthalmol. Visual Sci. 25:1436-1440.
100. Gressens, P., and J. R. Martin. 1994. In situ polymerase chain reaction: localization of HSV-2 DNA sequences in infections of the nervous system. J. Virol. Methods 46:61-83.
101. Halford, W. P., B. M. Gebhardt, and D. J. J. Carr. 1996. Persistent cytokine expression in trigeminal ganglion latently infected with herpes simplex virus type 1. J. Immunol. 157:3542-3549.
102. Harris, R. A., R. D. Everett, X. X. Zhu, S. J. Silverstein, and C. M. Preston. 1989. Herpes simplex virus type 1 immediate-early protein Vmw110 reactivates latent herpes simplex virus type 2 in an in vitro latency system. J. Virol. 63:3513-3515.
103. Harris, R. A., and C. M. Preston. 1991. Establishment of latency in vitro by the herpes simplex virus type 1 mutant in 1814. J. Gen. Virol. 72:907-913.
104. Hayward, S. D., and J. M. Hardwick. 1991. Epstein-Barr virus transactivators and their role in reactivation, p. 363-376. In E. K. Wagner (ed.), Herpesvirus transcription and its regulation. CRC Press, Inc., Boca Raton, Fla.
105. Henderson, E. E. 1988. Physicochemical-viral synergism during Epstein-Barr virus infection: a review. J. Natl. Cancer Inst. 80:476-483.
106. Hendricks, R. L., and T. M. Tumpey. 1990. Contribution of virus and immune factors to herpes simplex virus type I-induced comeal pathology. Invest. Ophthalmol. Visual Sci. 31:1929-1939.
107. Hill, A., P. Jugovic, I. York, G. Russ, J. Bennink, J. Yewdell, H. Ploegh, and D. Johnson. 1995. Herpes simplex virus turns off the TAP to evade host immunity. Nature 375:411-115.
108. Hill, J. M., J. B. Dudley, Y. Shimomura, and H. E. Kaufman. 1986. Quantitation and kinetics of adrenergic induced HSV-1 ocular shedding. Curr. Eye Res. 5:241-246.
109. Hill, J. M., B. M. Gebhardt, R. J. Wen, A. M. Bouterie, H. W. Thompson, R. J. O'Callaghan, W. P. Halford, and H. E. Kaufman. 1996. Quantitation of herpes simplex virus type 1 DNA and latency-associated transcripts in rabbit trigeminal ganglia demonstrates a stable reservoir of viral nucleic acids during latency. J. Virol. 70:3137-3141.
110. Hill, J. M., Y. Haruta, and D. S. Rootman. 1987. Adrenergically induced recurrent HSV-1 corneal epithelial lesions. Curr. Eye Res. 6:1065-1071.
111. Hill, J. M., J. B. Maggioncalda, H. H. Garza, Jr., Y. H. Su, N. W. Fraser, and T. M. Block. 1996. In vivo epinephrine reactivation of ocular herpes simplex virus type 1 in the rabbit is correlated to a 370-base-pair region located between the promoter and the 5′ end of the 2.0-kilobase latency-associated transcript. J. Virol. 70:7270-7274.
112. Hill, J. M., M. A. Rayfield, and Y. Haruta. 1987. Strain specificity of spontaneous and adrenergically induced HSV-1 ocular reactivation in latently infected rabbits. Curr. Eye Res. 6:91-97.
113. Hill, J. M., F. Sedarati, R. T. Javier, E. K. Wagner, and J. G. Stevens. 1990. Herpes simplex virus latent phase transcription facilitates in vivo reactivation. Virology 174:117-125.
114. Hill, T. J., D. A. Harbour, and W. A. Blyth. 1980. Isolation of herpes simplex virus from the skin of clinically normal mice during latent infection. J. Gen. Virol. 47:205-207.
115. Ho, D. Y., and E. S. Mocarski. 1989. Herpes simplex virus latent RNA (LAT) is not required for latent infection in the mouse. Proc. Natl. Acad. Sci. USA 86:7596-7600.
116. Hossain, A., L. M. Schang, and C. Jones. 1995. Identification of gene products encoded by the latency-related gene of bovine herpesvirus 1. J. Virol. 69:5345-5352.
117. Howard, M. K., C. Mailhos, C. L. Dent, and D. S. Latchman. 1993. Transactivation by the herpes simplex virus virion protein Vmw65 and viral permissivity in a neuronal cell line with reduced levels of the cellular transcription factor Oct-1. Exp. Cell Res. 207:194-196.
118. Hufert, F. T., T. Diebold, B. Ermisch, D. Von Laer, U. Meyer-König, and D. Neumann-Haefelin. 1995. Liver failure due to disseminated HSV-1 infection in a newborn twin. Scand. J. Infect. Dis. 27:627-629.
119. Izumi, K. M., A. M. McKelvey, G. B. Devi-Rao, E. K. Wagner, and J. G. Stevens. 1989. Molecular and biological characterization of a type 1 herpes simplex virus (HSV-1) specifically deleted for expression of the latency-associated transcript (LAT). Microb. Pathog. 7:121-134.
120. Izumi, K. M., and J. G. Stevens. 1990. Molecular and biological characterization of a herpes simplex virus type 1 (HSV-1) neuroinvasiveness gene. J. Exp. Med. 172:487-496.
121. Jacobson, J. G., D. A. Leib, D. J. Goldstein, C. L. Bogard, P. A. Schaffer, S. K. Weller, and D. M. Coen. 1989. A herpes simplex virus ribonucleotide reductase deletion mutant is defective for productive acute and reactivatable latent infections of mice and for replication in mouse cells. Virology 173:276-283.
122. Jamieson, D. R. S., L. H. Robinson, J. I. Daksis, M. J. Nicholl, and C. M. Preston. 1995. Quiescent viral genomes in human fibroblasts after infection with herpes simplex virus type 1 Vmw65 mutants. J. Gen. Virol. 76:1417-1431.
123. Jamieson, G. A., N. J. Maitland, G. K. Wilcock, C. M. Yates, and R. F. Itzhaki. 1992. Herpes simplex virus type 1 DNA is present in specific regions of brain from aged people with and without senile dementia of the Alzheimer type. J. Pathol. 167:365-368.
124. Javier, R. T., K. M. Izumi, and J. G. Stevens. 1988. Localization of a herpes simplex virus neurovirulence gene dissociated from high-titer virus replication in the brain. J. Virol. 62:1381-1387.
125. Javier, R. T., J. G. Stevens, V. B. Dissette, and E. K. Wagner. 1988. A herpes simplex virus transcript abundant in latently infected neurons is dispensable for establishment of the latent state. Virology 166:254-257.
126. Joklik, W. K. 1997. Interferons, p. 383-410. In B. N. Fields and D. M. Knipe (ed.), Virology. Raven Press, New York, N.Y.
127. Kanangat, S., J. Thomas, S. Gangappa, J. S. Babu, and B. T. Rouse. 1996. Herpes simplex virus type 1-mediated up-regulation of IL-12 (p40) mRNA expression - implications in immunopathogenesis and protection. J. Immunol. 156:1110-1116.
128. Kapoor, A. K., A. A. Nash, and P. Wildy. 1982. Pathogenesis of herpes simplex virus in B cell-suppressed mice: the relative roles of cell-mediated and humoral immunity. J. Gen. Virol. 61:127-131.
129. Katz, J. P., E. T. Bodin, and D. M. Coen. 1990. Quantitative polymerase chain reaction analysis of herpes simplex virus DNA in ganglia of mice infected with replication-incompetent mutants. J. Virol. 64:4288-4295.
130. Kaye, S. B., C. Lynas, A. Patterson, J. M. Risk, K. McCarthy, and C. A. Hart. 1991. Evidence for herpes simplex viral latency in the human cornea. Br. J. Ophthalmol. 75:195-200.
131. Kennedy, P. G., S. A. Al-Saadi, and G. B. Clements. 1983. Reactivation of latent herpes simplex virus from dissociated identified dorsal root ganglion cells in culture. J. Gen. Virol. 64:1629-1635.
132. Kenny, J. J., F. C. Krebs, H. T. Hartle, A. E. Gartner, B. Chatton, J. M. Leiden, J. P. Hoeffler, P. C. Weber, and B. Wigdahl. 1994. Identification of a second ATF/CREB-like element in the herpes simplex virus type 1 (HSV-1) latency-associated transcript (LAT) promoter. Virology 200:220-235.
133. Knipe, D. M., D. Senechek, S. A. Rice, and J. L. Smith. 1987. Stages in the nuclear association of the herpes simplex virus transcriptional activator protein ICP4. J. Virol. 61:276-284.
134. Knotts, F. B., M. L. Cook, and J. G. Stevens. 1973. Latent herpes simplex virus in the central nervous system of rabbits and mice. J. Exp. Med. 138:740-744.
135. Koffa, M., E. Koomantakis, M. Ergazaki, C. Tsatsanis, and D. A. Spandidos. 1995. Association of herpesvirus infection with the development of genital cancer. Int. J. Cancer 63:58-62.
136. Kramer, M. F., and D. M. Coen. 1995. Quantification of transcripts from the ICP4 and thymidine kinase genes in mouse ganglia latently infected with herpes simplex virus. J. Virol. 69:1389-1399.
137. Krause, P. R., K. D. Croen, S. E. Straus, and J. M. Ostrove. 1988. Detection and preliminary characterization of herpes simplex virus type 1 transcripts in latently infected human trigeminal ganglia. J. Virol. 62:4819-4823.
138. Krause, P. R., J. M. Ostrove, and S. E. Straus. 1991. The nucleotide sequence, 5′ end, promoter domain, and kinetics of expression of the gene encoding the herpes simplex virus type 2 latency-associated transcript. J. Virol. 65:5619-5623.
139. Krause, P. R., L. R. Stanberry, N. Bourne, B. Connelly, J. F. Kurawadwala, A. Patel, and S. E. Straus. 1995. Expression of the herpes simplex virus type 2 latency-associated transcript enhances spontaneous reactivation of genital herpes in latently infected guinea pigs. J. Exp. Med. 181:297-306.
140. Kristensson, K., E. Lycke, and J. Sjöstrand. 1971. Spread of herpes simplex virus in peripheral nerves. Acta Neuropathol. 17:44-53.
141. Kulkarni, A. G., and N. S. Brid. 1995. Herpes zoster. N. Engl. J. Med. 332:1684.
142. Kumano, Y., M. Yamamoto, and R. Mori. 1987. Protection against herpes simplex virus infection in mice by recombinant murine interferon-beta in combination with antibody. Antiviral Res. 7:289-301.
143. Kwon, B. S., L. P. Gangarosa, K. D. Burch, J. deBack, and J. M. Hill. 1981. Induction of ocular herpes simplex virus shedding by iontophoresis of epinephrine into rabbit cornea. Invest. Ophthalmol. Visual Sci. 21:442-449.
144. Kwon, B. S., L. P. Gangarosa, K. Green, and J. M. Hill. 1982. Kinetics of ocular herpes simplex virus shedding induced by epinephrine inotophoresis. Invest. Ophthalmol. Visual Sci. 22:818-821.
145. Lagunoff, M., G. Randall, and B. Roizman. 1996. Phenotypic properties of herpes simplex virus 1 containing a derepressed open reading frame P gene. J. Virol. 70:1810-1817.
146. 134.5 gene and transcribed by an RNA 3′ coterminal with the unspliced latency-associated transcript. J. Virol. 68:6021-6028.
147. Lancz, G. J. and T. L. Zettlemoyer. 1976. Restricted replication of herpes simplex virus in neural cells. Proc. Soc. Exp. Biol. Med. 152:302-306.
148. Landry, M. L. and C. Bull. 1992. Herpes simplex types 1 and 2: latency in the genital tract of guinea pigs. Intervirology 33:204-210.
149. Laycock, K. A., S. F. Lee, R. H. Brady, and J. S. Pepose. 1991. Characterization of a murine model of recurrent herpes simplex viral keratitis induced by ultraviolet B radiation. Invest. Ophthalmol. Visual Sci. 32:2741-2746.
150. Leib, D. A., C. L. Bogard, M. Kosz-Vnenchak, K. A. Hicks, D. M. Coen, D. M. Knipe, and P. A. Schaffer. 1989. A deletion mutant of the latency-associated transcript of herpes simplex virus type 1 reactivates from the latent state with reduced frequency. J. Virol. 63:2893-2900.
151. Leib, D. A., D. M. Coen, C. L. Bogard, K. A. Hicks, D. R. Yager, D. M. Knipe, K. L. Tyler, and P. A. Schaffer. 1989. Immediate-early regulatory eene mutants define different stages in the establishment and reactivation of herpes simplex virus latency. J. Virol. 63:759-768.
152. Leib, D. A., K. C. Nadeau, S. A. Rundle, and P. A. Schaffer. 1991. The promoter of the latency-associated transcripts of herpes simplex virus type 1 contains a functional cAMP-response element: role of the latency-associated transcripts and cAMP in reactivation of viral latency. Proc. Natl. Acad. Sci. USA 88:48-52.
153. Leopardi, R., P. L. Ward, W. O. Ogle, and B. Roizman. 1996. Association of ICP4 and ICP22 with RNA POLII and nascent viral DNA defines late transcriptional compartments in HSV-1 infected cells, abstr. 1. In 21st Herpesvirus Workshop 1.
154. Levine, M., D. J. Fink, R. Ramakrishnan, P. Desai, W. F. Goins, and J. C. Glorioso. 1994. Neurovirulence of herpes simplex virus type 1 accessory gene mutants, p. 222-237. In Y. Becker and G. Darai (ed.), Pathogenicity of human herpesviruses due to specific pathogenicity genes. Springer-Verlag KG, Berlin, Germany.
155. Levy, J. A. 1995. A new human herpesvirus: KSHV or HHV8? Lancet 346:786.
156. Lillycrop, K. A., C. L. Dent, S. C. Wheatley, M. N. Beech, N. N. Ninkina, J. N. Wood, and D. S. Latchman. 1991. The octamer-binding protein Oct-2 represses HSV immediate-early genes in cell lines derived from latently infectable sensory neurons. Neuron 7:381-390.
157. Lillycrop, K. A., M. K. Howard, J. K. Estridge, and D. S. Latchman. 1994. Inhibition of herpes simplex virus infection by ectopic expression of neuronal splice variants of the Oct-2 transcription factor. Nucleic Acids Res. 22:815-820.
158. Lokensgard, J. R., D. C. Bloom, A. T. Dobson, and L. T. Feldman. 1994. Long-term promoter activity during herpes simplex virus latency. J. Virol. 68:7148-7158.
159. Lokensgard, J. R., D. G. Thawley, and T. W. Molitor. 1990. Pseudorabies virus latency: restricted transcription. Arch. Virol. 110:129-136.
160. Lycke, E., M. Johansson, B. Svennerholm, and U. Lindahl. 1991. Binding of herpes simplex virus to cellular heparan sulphate, an initial step in the adsorption process. J. Gen. Virol. 72:1131-1137.
161. Lynas, C., T. J. Hill, N. J. Maitland, and S. Love. 1993. Latent infection with the MS strain of herpes simplex virus type 2 in the mouse following intracerebral inoculation. J. Neurol. Sci. 120:107-114.
162. Mador, N., A. Panet, D. Latchman, and I. Steiner. 1995. Expression and splicing of the latency-associated transcripts of herpes simplex virus type 1 in neuronal and non-neuronal cell lines. J. Biochem. (Tokyo) 117:1288-1297.
163. Maggioncalda, J., A. Mehta, N. W. Fraser, and T. M. Block. 1994. Analysis of a herpes simplex virus type 1 LAT mutant with a deletion between the putative promoter and the 5′ end of the 2.0-kilobase transcript. J. Virol. 68:7816-7824.
164. Maggioncalda, J., A. Mehta, Y. H. Su, N. W. Fraser, and T. M. Block. 1996. Correlation between herpes simplex virus type 1 rate of reactivation from latent infection and the number of infected neurons in trigeminal ganglia. Virology 225:72-81.
165. Mahalingam, R., M. C. Wellish, A. N. Dueland, R. J. Cohrs, and D. H. Gilden. 1992. Localization of herpes simplex virus and varicella zoster virus DNA in human ganglia. Ann. Neurol. 31:444-448.
166. Margolis, T. P., D. C. Bloom, A. T. Dobson, L. T. Feldman, and J. G. Stevens. 1993. Decreased reporter gene expression during latent infection with HSV LAT promoter constructs. Virology 197:585-592.
167. Margolis, T. P., C. R. Dawson, and J. H. LaVail. 1992. Herpes simplex viral infection of the mouse trigeminal ganglion: immunohistochemical analysis of cell populations. Invest. Ophthalmol. Visual Sci. 33:259-267.
168. Margolis, T. P., F. Sedarati, A. T. Dobson, L. T. Feldman, and J. G. Stevens. 1992. Pathways of viral gene expression during acute neuronal infection with HSV-1. Virology 189:150-160.
169. McGeoch, D. J. 1989. The genomes of the human herpesviruses: contents, relationships, and evolution. Annu. Rev. Microbiol. 43:235-265.
170. McGeoch, D. J., and S. Cook. 1994. Molecular phylogeny of the alphaher-pesvirinae subfamily and a proposed evolutionary timescale. J. Mol. Biol. 238:9-22.
171. McGeoch, D. J., S. Cook, A. Dolan, F. E. Jamieson, and E. A. R. Telford. 1995. Molecular phylogeny and evolutionary timescale for the family of mammalian herpesviruses. J. Mol. Biol. 247:443-458.
172. McGrath, B. J., and C. L. Newman. 1994. Genital herpes simplex infections in patients with the acquired immunodeficiency syndrome. Pharmacotherapy 14:529-542.
173. McLennan, J. L., and G. Darby. 1980. Herpes simplex virus latency: the cellular location of virus in dorsal root ganglia and the fate of the infected cell following virus activation. J. Gen. Virol. 51:233-243.
174. Mehta, A., J. Maggioncalda, O. Bagasra, S. Thikkavarapu, P. Saikumari, T. Valyi-Nagy, N. W. Fraser, and T. M. Block. 1995. In situ DNA PCR and RNA hybridization detection of herpes simplex virus sequences in trigeminal ganglia of latently infected mice. Virology 206:633-640.
175. Mellerick, D. M., and N. W. Fraser. 1987. Physical state of the latent herpes simplex virus genome in a mouse model system: evidence suggesting an episomal state. Virology 158:265-275.
176. Miller, R. F., J. D. Fox, P. Thomas, J. C. Waite, Y. Sharvell, B. G. Gazzard, M. J. G. Harrison, and N. S. Brink. 1996. Acute lumbosacral polyradiculopathy due to cytomegalovirus in advanced HIV disease: CSF findings in 17 patients. J. Neurol. Neurosurg. Psychiatry 61:456-460.
177. Mitchell, B. M., and J. G. Stevens. 1996. Neuroinvasive properties of herpes simplex virus type 1 Glycoprotein variants are controlled by the immune response. J. Immunol. 156:246-255.
178. Mitchell, W. J., S. L. Deshmane, A. Dolan, D. J. McGeoch, and N. W. Fraser. 1990. Characterization of herpes simplex virus type 2 transcription during latent infection of mouse trigeminal ganglia. J. Virol. 64:5342-5348.
179. Mitchell, W. J., R. P. Lirette, and N. W. Fraser. 1990. Mapping of low abundance latency-associated RNA in the trigeminal ganglia of mice latently infected with herpes simplex virus type 1. J. Gen. Virol. 71:125-132.
180. Mitchell, W. J., I. Steiner, S. M. Brown, A. R. MacLean, J. H. Subak-Sharpe, and N. W. Fraser. 1990. A herpes simplex virus type 1 variant, deleted in the promoter region of the latency-associated transcripts, does not produce any detectable minor RNA species during latency in the mouse trigeminal ganglion. J. Gen. Virol. 71:953-957.
181. Moriya, A., A. Yoshiki, M. Kita, S. Fushiki, and J. Imanishi. 1994. Heat shock-induced reactivation of herpes simplex virus type 1 in latently infected mouse trigeminal ganglion cells in dissociated culture. Arch. Virol. 135:419-425.
182. Morris, D. J., G. M. Cleator, P. E. Klapper, R. J. Cooper, E. O. E. Biney, C. Dennett, B. Marcyniuk, and A. B. Tullo. 1996. Detection of herpes simplex virus DNA in donor cornea culture medium by polymerase chain reaction. Br. J. Ophthalmol. 80:654-657.
183. Mullen, M.-A., S. Gerstberger, D. M. Ciufo, J. D. Mosca, and G. S. Hayward. 1995. Evaluation of colocalization interactions between the IE110, IE175, and IE63 transactivator proteins of herpes simplex virus within subcellular punctate structures. J. Virol. 69:476-491.
184. Nahmias, A. J., W. E. Josey, Z. M. Naib, M. G. Freeman, R. J. Fernandez, and J. H. Wheeler. 1971. Perinatal risk associated with maternal genital herpes simplex virus infection. Am. J. Obstet. Gynecol. 110:825-837.
185. Nash, A. A., and P. Cambouropoulos. 1993. The immune response to herpes simplex virus. Semin. Virol. 4:181-186.
186. Nash, A. A., and P. G. Gell. 1983. Membrane phenotype of murine effector and suppressor T cells involved in delayed hypersensitivity and protective immunity to herpes simplex virus. Cell. Immunol. 75:348-355.
187. Nash, A. A., A. Jayasuriya, J. Phelan, S. P. Cobbold, H. Waldmann, and T. Prospero. 1987. Different roles for L3T4+ and Lyt 2+ T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system. J. Gen. Virol. 68:825-833.
188. Nash, A. A., and J. M. Lohr. 1992. Pathogenesis and immunology of herpesvirus infection of the nervous system, p. 155-175. In S. Spector, M. Bendinelli, and H. Friedman (ed.), Neuropathogenic viruses and immunity. Plenum Press, New York, N.Y.
189. Natarajan, R., S. Deshmane, T. Valyi-Nagy, R. D. Everett, and N. W. Fraser. 1991. A herpes simplex virus type 1 mutant lacking the ICP0 introns reactivates with normal efficiency. J. Virol. 65:5569-5573.
190. Nesburn, A. B., M. L. Cook, and J. G. Stevens. 1972. Latent herpes simplex virus: isolation from rabbit trigeminal ganglia between episodes of recurrent ocular infection. Arch. Ophthalmol. 88:412-417.
191. Nesburn, A. B., J. H. Elliott, and H. M. Leibowitz. 1967. Spontaneous reactivation of experimental herpes simplex keratitis in rabbits. Arch. Ophthalmol. 78:523-529.
192. Nicoll, J. A. R., S. Love, and E. Kinrade. 1993. Distribution of herpes simplex virus DNA in the brains of human long-term survivors of encephalitis. Neurosci. Lett. 157:215-218.
193. Nicosia, M., J. M. Zabolotny, R. P. Lirette, and N. W. Fraser. 1994. The HSV-1 2-kb latency-associated transcript is found in the cytoplasm comigrating with ribosomal subunits during productive infection. Virology 204: 717-728.
194. Okazaki, H., and T. Sekitani. 1993. Experimental reactivation of HSV-1 in rat vestibular ganglia. Acta Otolaryngol. (Stockh.) 113(Suppl. 503):90-92.
195. Olivo, P. D., and M. D. Challberg. 1991. Functional analysis of the herpes simplex virus gene products involved in DNA replication, p. 137-150. In E. K. Wagner (ed.), Herpesvirus transcription and its regulation. CRC Press, Inc., Boca Raton, Fla.
196. Olson, L. C., E. L. Buescher, M. S. Artenstein, and P. D. Parkman. 1967. Herpesvirus infections of the human central nervous system. N. Engl. J. Med. 277:1271-1277.
197. O'Neill, F. J. 1977. Prolongation of herpes simplex virus latency in cultured human cells by temperature elevation. J. Virol. 24:41-46.
198. O'Neill, F. J., R. J. Goldberg, and F. Rapp. 1972. Herpes simplex virus latency in cultured human cells following treatment with cytosine arabinoside. J. Gen. Virol. 14:189-197.
199. Openshaw, H., J. I. McNeill, X. H. Lin, J. Niland, and E. M. Cantin. 1995. Herpes simplex virus DNA in normal corneas: persistence without viral shedding from ganglia. J. Med. Virol. 46:75-80.
200. Oren, I., and J. D. Sobel. 1992. Human herpesvirus type 6: review. Clin. Infect. Dis. 14:741-746.
201. Ostrove, J. M. 1990. Molecular biology of varicella zoster virus. Adv. Virus Res. 38:45-98.
202. Pass, R. F., R. J. Whitley, J. D. Whelchel, A. G. Diethelm, D. W. Reynolds, and C. A. Alford. 1979. Identification of patients with increased risk of infection with herpes simplex virus after renal transplantation. J. Infect. Dis. 140:487-492.
203. Pearson, G. R. 1993. Epstein-Barr virus and nasopharyngeal carcinoma. J. Cell. Biochem. Suppl. 17F:150-154.
204. Perng, G. C., K. Chokephaibulkit, R. L. Thompson, N. M. Sawtell, S. M. Slanina, H. Ghiasi, A. B. Nesburn, and S. L. Wechsler. 1996. The region of the herpes simplex virus type 1 LAT gene that is colinear with the ICP34.5 gene is not involved in spontaneous reactivation. J. Virol. 70:282-291.
205. Perng, G. C., E. C. Dunkel, P. A. Geary, S. M. Slanina, H. Ghiasi, R. Kaiwar, A. B. Nesburn, and S. L. Wechsler. 1994. The latency-associated transcript gene of herpes simplex virus type 1 (HSV-1) is required for efficient in vivo spontaneous reactivation of HSV-1 from latency. J. Virol. 68:8045-8055.
206. Perng, G. C., H. Ghiasi, S. M. Slanina, A. B. Nesburn, and S. L. Wechsler. 1996. High-dose ocular infection with a herpes simplex virus type 1 ICP34.5 deletion mutant produces no corneal disease or neurovirulence yet results in wild-type levels of spontaneous reactivation. J. Virol. 70:2883-2893.
207. Perng, G. C., H. Ghiasi, S. M. Slanina, A. B. Nesburn, and S. L. Wechsler. 1996. The spontaneous reactivation function of the herpes simplex virus type 1 LAT gene resides completely within the first 1.5 kilobases of the 8.3-kilobase primary transcript. J. Virol. 70:976-984.
208. Perng, G. C., S. M. Slanina, H. Ghiasi, A. B. Nesburn, and S. L. Wechsler. 1996. A 371-nucleotide region between the herpes simplex virus type 1 (HSV-1) LAT promoter and the 2-kilobase LAT is not essential for efficient spontaneous reactivation of latent HSV-1. J. Virol. 70:2014-2018.
209. Perry, L. J., F. J. Rixon, R. D. Everett, M. C. Frame, and D. J. McGeoch. 1986. Characterization of the IE110 gene of herpes simplex virus type 1. J. Gen. Virol. 67:2365-2380.
210. Peterslund, N. A. 1991. Herpesvirus infection: an overview of the clinical manifestations. Scand. J. Infect. Dis. Suppl. 80:15-20.
211. Peyman, A., M. Helsberg, G. Kretzschmar, M. Mag, S. Grabley, and E. Uhlmann. 1995. Inhibition of viral growth by antisense oligonucleotides directed against the IE110 and the UL30 mRNA of herpes simplex virus type-1. Biol. Chem. Hoppe-Seyler 376:195-198.
212. Poffenberger, K. L., A. D. Idowu, E. B. Fraser-Smith, P. E. Raichlen, and R. C. Herman. 1994. A herpes simplex virus type 1 ICP22 deletion mutant is altered for virulence and latency in vivo. Arch. Virol. 139:111-119.
213. Preston, C. M., and J. Russell. 1991. Retention of nonlinear viral DNA during herpes simplex virus latency in vitro. Intervirology 32:69-75.
214. Priola, S. A., D. P. Gustafson, E. K. Wagner, and J. G. Stevens. 1990. A major portion of the latent pseudorabies virus genome is transcribed in trigeminal ganglia of pigs. J. Virol. 64:4755-4660.
215. Priola, S. A., and J. G. Stevens. 1991. Localization of the 5′ and 3′ ends of transcription of the pseudorabies virus latency associated transcription unit. Virology 182:852-856.
216. L13 protein kinase determines the accumulation of a subset of α and gamma mRNAs and proteins in infected cells. Proc. Natl. Acad. Sci. USA 90:6701-6705.
217. Quinlan, M. P., and D. M. Knipe. 1983. Nuclear localization of herpesvirus proteins: potential role for the cellular framework. Mol. Cell Biol. 3:315-324.
218. Rader, K. A., C. E. Ackland-Berglund, J. K. Miller, J. S. Pepose, and D. A. Leib. 1993. In vivo characterization of site-directed mutations in the promoter of the herpes simplex virus type 1 latency-associated transcripts. J. Gen. Virol. 74:1859-1869.
219. Ramakrishnan, R., D. J. Fink, G. Jiang, P. Desai, J. C. Glorioso, and M. Levine. 1994. Competitive quantitative PCR analysis of herpes simplex virus type 1 DNA and latency-associated transcript RNA in latently infected cells of the rat brain. J. Virol. 68:1864-1873.
220. Ramakrishnan, R., M. Levine, and D. J. Fink. 1994. PCR-based analysis of herpes simplex virus type 1 latency in the rat trigeminal ganglion established with a ribonucleotide reductase-deficient mutant. J. Virol. 68:7083-7091.
221. Ramakrishnan, R., P. L. Poliani, M. Levine, J. C. Glorioso, and D. J. Fink. 1996. Detection of herpes simplex virus type 1 latency-associated transcript expression in trigeminal ganglia by in situ reverse transcriptase PCR. J. Virol. 70:6519-6523.
222. Rand, K. H., K. I. Berns, and M. A. Rayfield. 1984. Recovery of herpes simplex type 1 from the celiac ganglion after renal transplantation. South. Med. J. 77:403-404.
223. Reeves, W. C., L. Corey, H. G. Adams, L. A. Vontver, and K. K. Holmes. 1981. Risk of recurrence after first episodes of genital herpes. Relation to HSV type and antibody response. N. Engl. J. Med. 305:315-319.
224. Rice, M. K., G. B. Devi-Rao, and E. K. Wagner. 1993. Latent phase transcription by alphaherpesviruses, p. 305-324. In K. W. Adolph (ed.), Genome research in molecular medicine and virology. Academic Press, Inc., Orlando, Fla.
225. Rivera-Gonzalez, R., A. N. Imbalzano, B. Gu, and N. A. DeLuca. 1994. The role of ICP4 repressor activity in temporal expression of the IE-3 and latency-associated transcript promoters during HSV-1 infection. Virology 202:550-564.
226. Rock, D. L. 1994. Latent infection with bovine herpesvirus type 1. Semin. Virol. 5:233-240.
227. Rock, D. L., S. L. Beam, and J. E. Mayfield. 1987. Mapping bovine herpesvirus type 1 latency-related RNA in trigeminal ganglia of latently infected rabbits. J. Virol. 61:3827-3831.
228. Rock, D. L., and N. W. Fraser. 1983. Detection of the HSV-1 genome in the central nervous system of latently infected mice. Nature 302:523-525.
229. Rock, D. L., and N. W. Fraser. 1985. Latent herpes simplex virus type 1 DNA contains two copies of the virion joint region. J. Virol. 62:3820-3826.
230. Rock, D. L., W. A. Hagemoser, F. A. Osorio, and H. A. McAllister. 1988. Transcription from the pseudorabies virus genome during latent infection. Brief report. Arch. Virol. 98:99-106.
231. Rock, D. L., W. A. Hagemoser, F. A. Osorio, and D. E. Reed. 1986. Detection of bovine herpesvirus type 1 RNA in trigeminal ganglia of latently infected rabbits by in situ hybridization. J. Gen. Virol. 67:2515-2520.
232. Rock, D. L., A. B. Nesburn, H. Ghiasi, J. Ong, T. L. Lewis, J. R. Lokensgard, and S. L. Wechsler. 1987. Detection of latency-related viral RNAs in trigeminal ganglia of rabbits latently infected with herpes simplex virus type 1. J. Virol. 61:3820-3826.
233. Rodahl, E. and L. Haarr. 1987. Analysis of the 2-kilobase latency-associated transcript expressed in PC12 cells productively infected with herpes simplex virus 1: evidence for a stable, nonlinear structure. J. Virol. 71:1703-1707.
234. Rodda, S., I. Jack, and D. O. White. 1973. Herpes-simplex virus from trigeminal ganglion. Lancet i:1395-1396.
235. Roizman, B. 1982. The family herpesviridae: general description, taxonomy, and classification, p. 1-23. In B. Roizman (ed.), The herpesviruses. Plenum Press, New York, N.Y.
236. Roizman, B., and A. E. Sears. 1990. Herpes simplex viruses and their replication, p. 1795-1842. In B. N. Fields, D. M. Knipe, R. M. Chanock, M. S. Hirsch, J. L. Melnick, T. P. Monath, and B. Roizman (ed.), Virology. Raven Press, New York, N.Y.
237. Rootman, D. S., Y. Haruta, and J. M. Hill. 1990. Reactivation of HSV-1 in primates by transcorneal iontophoresis of adrenergic agents. Invest. Ophthalmol. Visual Sci. 31:597-600.
238. Rosen-Wolff, A., J. Scholz, and G. Darai. 1989. Organotropism of latent herpes simplex virus type 1 is correlated to the presence of a 1.5 kb RNA transcript mapped within the BamHI DNA fragment B (0.738 to 0.809 map units). Virus Res. 12:43-51.
239. Ruyechan, W. T., P. Ling, P. R. Kinchington, and J. Hay. 1991. The correlation between varicella-zoster virus transcription and the sequence of the viral genome, p. 301-318. In E. K. Wagner (ed.), Herpesvirus transcription and its regulation. CRC Press, Inc., Boca Raton, Fla.
240. Sacks, W. R., and P. A. Schaffer. 1987. Deletion mutants in the gene encoding the herpes simplex virus type 1 immediate-early protein ICP0 exhibit impaired growth in cell culture. J. Virol. 61:829-839.
241. Sacks, W. R., and P. A. Schaffer. 1994. Deletion mutants in the gene encoding the herpes simplex virus type 1 immediate-early protein ICP0 exhibit impaired growth in cell culture. J. Virol. 61:829-839.
242. Salim, A. S. 1993. Reducing the recurrence rate of duodenal ulceration after highly selective vagotomy: a study in the rat and in man. J. Surg. Res. 55:493-498.
243. Sandri-Goldin, R. M., R. E. Sekulovich, and K. Leary. 1990. The alpha protein ICP0 does not appear to play a major role in the regulation of herpes simplex virus gene expression during infection in tissue culture. Nucleic Acids Res. 15:905-919.
244. Sawtell, N. M., and R. L. Thompson. 1992. Rapid in vivo reactivation of herpes simplex virus in latently infected murine ganglionic neurons after transient hyperthermia. J. Virol. 66:2150-2156.
245. Sawtell, N. M., and R. L. Thompson. 1992. Herpes simplex virus type 1 latency-associated transcription unit promotes anatomical site-dependent establishment and reactivation from latency. J. Virol. 66:2157-2169.
246. Schalling, M., M. Ekman, E. E. Kaaya, A. Linde, and P. Biberfeld. 1995. A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma. Nat. Med. 1:707-708.
247. Schang, L. M., A. Hossain, and C. Jones. 1996. The latency-related gene of bovine herpesvirus 1 encodes a product which inhibits cell cycle progression. J. Virol. 70:3807-3814.
248. Scheck, A. C., B. Wigdahl, and F. Rapp. 1989. Transcriptional activity of the herpes simplex virus genome during establishment, maintenance, and reactivation of in vitro virus latency. Intervirology 30:121-136.
249. - T cells and is restricted to the DR region of the MHC complex. J. Immunol. 140:3610-3616.
250. Schmid, D. S., and B. T. Rouse. 1992. The role of T cell immunity in control of herpes simplex virus. Curr. Top. Microbiol. Immunol. 179:57-74.
251. Sedarati, F., K. M. Izumi, E. K. Wagner, and J. G. Stevens. 1989. Herpes simplex virus type 1 latency-associated transcription plays no role in establishment or maintenance of a latent infection in murine sensory neurons. J. Virol. 63:4455-4458.
252. Sedarati, F., T. P. Margolis, and J. G. Stevens. 1993. Latent infection can be established with drastically restricted transcription and replication of the HSV-1 genome. Virology 192:687-691.
253. Seid, M., K. N. Leung, C. Pye, J. Phelan, A. A. Nash, and H. P. Godfrey. 1987. Clonal analysis of the T-cell response of mice to herpes simplex virus: correlation between lymphokine production in vitro and the induction of delayed-type hypersensitivity and antiviral activity in vivo. Viral Immunol. 1:35-14.
254. Sequiera, L. W., L. C. Jennings, L. H. Carrasco, M. A. Lord, A. Curry, and R. N. Sutton. 1979. Detection of herpes-simplex viral genome in brain tissue. Lancet ii:609-612.
255. Shao, L., L. M. Rapp, and S. K. Weller. 1993. Herpes simplex virus 1 alkaline nuclease is required for efficient egress of capsids from the nucleus. Virology 196:146-162.
256. Shimogori, H., T. Sekitani, Y. Koyanagi, and N. Yamamoto. 1991. Latent HSV-1 infection in rat vestibular ganglia. Acta Otolaryngol. (Stockh.) 111: 1031-1036.
257. Shimogori, H., T. Sekitani, H. Okazaki, and T. Hirata. 1993. Detection of HSV-1 nucleic acids in rat vestibular ganglia. Acta Otolaryngol. (Stockh.) 113(Suppl. 503):82-84.
258. Silins, S. L., and T. B. Sculley. 1995. Burkitt's lymphoma cells are resistant to programmed cell death in the presence of the Epstein-Barr virus latent antigen EBNA-4. Int. J. Cancer 60:65-72.
259. Simmons, A., and A. A. Nash. 1987. Effect of B cell suppression on primary infection and reinfection of mice with herpes simplex virus. J. Infect. Dis. 155:649-654.
260. Simmons, A., D. Tscharke, and P. Speck. 1992. The role of immune mechanisms in control of herpes simplex virus infection of the peripheral nervous system. Curr. Top. Microbiol. Immunol. 179:31-56.
261. Simmons, A., and D. C. Tscharke. 1992. Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: implications for the fate of virally infected neurons. J. Exp. Med. 175:1337-1344.
262. Sinclair, J., and J. G. P. Sissons. 1994. Human cytomegalovirus: pathogenesis and models of latency. Semin. Virol. 5:249-258.
263. Sköldenberg, B. 1991. Herpes simplex encephalitis. Scand. J. Infect. Dis. 23(Suppl. 80):40-46.
264. Smibert, C. A., B. Popova, P. Xiao, J. P. Capone, and J. R. Smiley. 1994. Herpes simplex virus VP16 forms a complex with the virion host shutoff protein vhs. J. Virol. 68:2339-2346.
265. Smith, R. L., L. I. Pizer, E. M. Johnson, Jr., and C. L. Wilcox. 1992. Activation of second-messenger pathways reactivates latent herpes simplex virus in neuronal cultures. Virology 188:311-318.
266. Snowden, B. W., E. D. Blair, and E. K. Wagner. 1988. Transcriptional activation with concurrent or nonconcurrent template replication has differential effects on transient expression from herpes simplex virus promoters. Virus Genes 2:129-145.
267. Soares, K., D. Y. Hwang, R. Ramakrishnan, M. C. Schmidt, D. J. Fink, and J. C. Glorioso. 1996. cis-acting elements involved in transcriptional regulation of the herpes simplex virus type 1 latency-associated promoter 1 (LAP1) in vitro and in vivo. J. Virol. 70:5384-5394.
268. Speck, P. G., and A. Simmons. 1991. Divergent molecular pathways of productive and latent infection with a virulent strain of herpes simplex virus type 1. J. Virol. 65:4001-4005.
269. Spivack, J. G., and N. W. Fraser. 1988. Expression of herpes simplex virus type 1 latency-associated transcripts in the trigeminal ganglia of mice during acute infection and reactivation of latent infection. J. Virol. 62:1479-1485.
270. Spivack, J. G., and N. W. Fraser. 1988. Expression of herpes simplex virus type 1 (HSV-1) latency-associated transcripts and transcripts affected by the deletion in avirulent mutant HFEM: evidence for a new class of HSV-1 genes. J. Virol. 62:3281-3287.
271. Spivack, J. G., G. M. Woods, and N. W. Fraser. 1991. Identification of a novel latency-specific splice donor signal within the herpes simplex virus type 1 2.0-kilobase latency-associated transcript (LAT): translation inhibition of LAT open reading frames by the intron within the 2.0-kilobase LAT. J. Virol. 65:6800-6810.
272. Stanberry, L. R., S. A. Floyd-Reising, B. L. Connelly, S. J. Alter, M. J. Gilchrist, C. Rubio, and M. G. Myers. 1994. Herpes simplex viremia: report of eight pediatric cases and review of the literature. Clin. Infect. Dis. 18:401-407.
273. Stanberry, L. R., E. R. Kern, J. T. Richards, T. M. Abbott, and J. C. Overall. 1982. Genital herpes in guinea pigs: pathogenesis of the primary infection and description of recurrent disease. J. Infect. Dis. 146:397-104.
274. Steiner, I., J. G. Spivack, S. L. Deshmane, C. I. Ace, C. M. Preston, and N. W. Fraser. 1990. A herpes simplex virus type 1 mutant containing a nontransinducing Vmw65 protein establishes latent infection in vivo in the absence of viral replication and reactivates efficiently from explanted trigeminal ganglia. J. Virol. 64:1630-1638.
275. Steiner, I., J. G. Spivack, R. P. Lirette, S. M. Brown, A. R. MacLean, J. H. Subak-Sharpe, and N. W. Fraser. 1989. Herpes simplex virus type 1 latency-associated transcripts are evidently not essential for latent infection. EMBO J. 8:505-511.
276. Stevens, J. G. 1975. Latent herpes simplex virus and the nervous system. Curr. Top. Microbiol. Immunol. 70:31-50.
277. Stevens, J. G. 1989. Human herpesviruses: a consideration of the latent state. Microbiol. Rev. 53:318-332.
278. Stevens, J. G. 1993. HSV-1 neuroinvasiveness. Intervirology 35:152-163.
279. Stevens, J. G., and M. L. Cook. 1971. Latent herpes simplex virus in spinal ganglia of mice. Science 173:843-845.
280. Stevens, J. G., and M. L. Cook. 1974. Maintenance of latent herpetic infection: an apparent role for anti-viral IgG. J. Immunol. 113:1685-1693.
281. Stevens, J. G., L. Haarr, D. D. Porter, M. L. Cook, and E. K. Wagner. 1988. Prominence of the herpes simplex virus latency-associated transcript in trigeminal ganglia from seropositive humans. J. Infect. Dis. 158:117-123.
282. Stevens, J. G., E. K. Wagner, G. B. Devi-Rao, M. L. Cook, and L. T. Feldman. 1987. RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons. Science 235:1056-1059.
283. Stow, N. D., and E. C. Stow. 1986. Isolation and characterization of a herpes simplex virus type 1 mutant containing a deletion within the gene encoding the immediate early polypeptide Vmw 110. J. Gen. Virol. 67:2571-2585.
284. Sugden, B. 1994. Latent infection of B lymphocytes by Epstein-Barr virus. Semin. Virol. 5:197-206.
285. Sugita, K., H. Kurumada, M. Eguchi, and T. Furukawa. 1995. Human herpesvirus 6 infection associated with hemophagocytic syndrome. Acta Haematol. 93:108-109.
286. Suzuki, S., and J. R. Martin. 1989. Herpes simplex virus type 2 transcripts in trigeminal ganglia during acute and latent infection in mice. J. Neurol. Sci. 93:239-251.
287. Tanaka, S., H. Minagawa, Y. Toh, Y. Liu, and R. Mori. 1994. Analysis by RNA-PCR of latency and reactivation of herpes simplex virus in multiple neuronal tissues. J. Gen. Virol. 75:2691-2698.
288. Tenser, R. B. 1994. The role of herpes simplex virus thymidine kinase expression in pathogenesis and latency, p. 68-86. In Y. Becker and G. Darai (ed.), Pathogenicity of human herpesvirus due to specific pathogenicity genes. Springer-Verlag KG, Berlin, Germany.
289. Tenser, R. B., W. A. Edris, K. A. Hay, and B. E. De Galan. 1991. Expression of herpes simplex virus type 2 latency-associated transcript in neurons and nonneurons. J. Virol. 65:2745-2750.
290. Tenser, R. B., and R. W. Hyman. 1987. Latent herpesvirus infections of neurons in guinea pigs and humans. Yale J. Biol. Med. 60:159-167.
291. Thompson, R. L., M. L. Cook, G. B. Devi-Rao, E. K. Wagner, and J. G. Stevens. 1986. Functional and molecular analysis of the avirulent wild-type herpes simplex virus type 1 strain KOS. J. Virol. 58:203-211.
292. Tomazin, R., A. B. Hill, P. Jugovic, I. York, P. Van Endert, H. L. Ploegh, D. W. Andrews, and D. C. Johnson. 1996. Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP. EMBO J. 15:3256-3266.
293. - T lymphocytes. J. Immunol. 142:1325-1332.
294. Trousdale, M. D., I. Steiner, J. G. Spivack, S. L. Deshmane, S. M. Brown, A. R. MacLean, J. H. Subak-Sharpe, and N. W. Fraser. 1991. In vivo and in vitro reactivation impairment of a herpes simplex virus type 1 latency-associated transcript variant in a rabbit eye model. J. Virol. 65:6989-6993.
295. Valyi-Nagy, T., S. L. Deshmane, B. Raengsakulrach, M. Nicosia, R. M. Gesser, M. Wysocka, A. Dillner, and N. W. Fraser. 1992. Herpes simplex virus type 1 mutant strain in 1814 establishes a unique, slowly progressing infection in SCID mice. J. Virol. 66:7336-7345.
296. Valyi-Nagy, T., S. L. Deshmane, J. G. Spivack, I. Steiner, C. I. Ace, C. M. Preston, and N. W. Fraser. 1991. Investigation of herpes simplex virus type 1 (HSV-1) gene expression and DNA synthesis during the establishment of latent infection by an HSV-1 mutant, in 1814, that does not replicate in mouse trigeminal ganglia. J. Gen. Virol. 72:641-649.
297. + gamma34.5 deletion mutant 1716 is avirulent in SCID mice. J. Gen. Virol. 75:2059-2063.
298. Varnell, E. D., H. E. Kaufman, J. M. Hill, and R. H. Wolf. 1987. A primate model for acute and recurrent herpetic keratitis. Curr. Eye Res. 6:277-279.
299. Wagner, E. K., G. B. Devi-Rao, L. T. Feldman, A. T. Dobson, Y. F. Zhang, W. M. Flanagan, and J. G. Stevens. 1988. Physical characterization of the herpes simplex virus latency-associated transcript in neurons. J. Virol. 62: 1194-1202.
300. Wagner, E. K., W. M. Flanagan, G. B. Devi-Rao, Y. F. Zhang, J. M. Hill, K. P. Anderson, and J. G. Stevens. 1988. The herpes simplex virus latency-associated transcript is spliced during the latent phase of infection. J. Virol. 62:4577-4585.
301. Wagner, E. K., J. F. Guzowski, and J. Singh. 1995. Transcription of the herpes simplex virus genome during productive and latent infection. Prog. Nucleic Acid Res. Mol. Biol. 51:123-168.
302. Wagner, E. K. 1994. Herpesvirus latency. Semin. Virol. 5:189-190.
303. Warren, K. G., S. M. Brown, Z. Wroblewska, D. Gilden, H. Koprowski, and J. Subak-Sharpe. 1978. Isolation of latent herpes simplex virus from the superior cervical and vagus ganglions of human beings. N. Engl. J. Med. 298:1068-1069.
304. Wechsler, S. L., A. B. Nesburn, R. Watson, S. Slanina, and H. Ghiasi. 1988. Fine mapping of the major latency-related RNA of herpes simplex virus type 1 in humans. J. Gen. Virol. 69:3101-3106.
305. Wechsler, S. L., A. B. Nesburn, R. Watson, S. M. Slanina, and H. Ghiasi. 1988. Fine mapping of the latency-related gene of herpes simplex virus type 1: alternative splicing produces distinct latency-related RNAs containing open reading frames. J. Virol. 62:4051-4058.
306. Wechsler, S. L., A. B. Nesburn, J. C. Zwaagstra, and H. Ghiasi. 1989. Sequence of the latency-related gene of herpes simplex virus type 1. Virology 168:168-172.
307. Weller, S. K. 1991. Genetic analysis of HSV genes required for genome replication, p. 105-136. In E. K. Wagner (ed.), Herpesvirus transcription and its regulation. CRC Press. Inc., Boca Raton, Fla.
308. Weller, T. H. 1992. Varicella and herpes zoster: a perspective and overview. J. Infect. Dis. 166(Suppl. 1):S1-S6.
309. Wheatley, S. C., C. L. Dent, J. N. Wood, and D. S. Latchman. 1992. Elevation of cyclic AMP levels in cell lines derived from latently infectable sensory neurons increases their permissivity for herpes virus infection by activating the viral immediate-early 1 gene promoter. Mol. Brain Res. 12:149-154.
310. Whitley, R. J. 1990. Herpes simplex viruses, p. 1843-1887. In B. N. Fields (ed.), Virology. Raven Press, New York, N.Y.
311. Whitley, R. J., and J. W. Gnann. 1993. The epidemiology and clinical manifestations of herpes simplex virus infections, p. 69-105. In B. Roizman, R. J. Whitely, and C. Lopez (ed.), The human herpesviruses. Raven Press, New York, N.Y.
312. Wigdahl, B., A. C. Scheck, R. J. Ziegler, E. De Clercq, and F. Rapp. 1984. Analysis of the herpes simplex virus genome during in vitro latency in human diploid fibroblasts and rat sensory neurons. J. Virol. 49:205-213.
313. Wigdahl, B., C. A. Smith, H. M. Traglia, and F. Rapp. 1984. Herpes simplex virus latency in isolated human neurons. Proc. Natl. Acad. Sci. USA 81: 6217-6221.
314. Wigdahl, B. L., A. C. Scheck, E. De Clercq, and F. Rapp. 1982. High efficiency latency and activation of herpes simplex virus in human cells. Science 217:1145-1146.
315. Wilcox, C. L., R. L. Smith, C. R. Freed, and E. M. Johnson, Jr. 1990. Nerve growth factor-dependence of herpes simplex virus latency in peripheral sympathetic and sensory neurons in vitro. J. Neurosci. 10:1268-1275.
316. Wilcox, C. M., D. A. Schwartz, and W. S. Clark. 1995. Esophageal ulceration in human immunodeficiency virus infection. Causes, response to therapy, and long-term outcome. Ann. Intern. Med. 123:143-149.
317. Wildy, P., and P. G. Gell. 1985. The host response to herpes simplex virus. Br. Med. Bull. 41:86-91.
318. Willey, D. E., M. D. Trousdale, and A. B. Nesburn. 1984. Reactivation of murine latent HSV infection by epinephrine iontophoresis. Invest. Ophthalmol. Visual Sci. 25:945-950.
319. Wu, C. A., N. J. Nelson, D. J. McGeoch, and M. D. Challberg. 1988. Identification of herpes simplex virus type 1 genes required for origin-dependent DNA synthesis. J. Virol. 62:435-443.
320. Wu, L., and P. S. Morahan. 1992. Macrophages and other nonspecific defenses: role in modulating resistance against herpes simplex virus. Curr. Top. Microbiol. Immunol. 179:89-110.
321. Wu, T. T., Y. H. Su, T. M. Block, and J. M. Taylor. 1996. Evidence that two latency-associated transcripts of herpes simplex virus type 1 are nonlinear. J. Virol. 70:5962-5967.
322. Yeh, L., and P. A. Schaffer. 1993. A novel class of transcripts expressed with late kinetics in the absence of ICP4 spans the junction between the long and short segments of the herpes simplex virus type 1 genome. J. Virol. 67: 7373-7382.
323. + T Lymphocytes. Cell 77:525-535.
324. Yoshikawa, T., J. M. Hill, L. R. Stanberry, N. Bourne, J. F. Kurawadwala, and P. R. Krause. 1996. The characteristic site-specific reactivation phenotypes of HSV-1 and HSV-2 depend upon the latency-associated transcript region. J. Exp. Med. 184:659-664.
325. Yoshikawa, T., L. R. Stanberry, N. Bourne, and P. R. Krause. 1996. Down-stream regulatory elements increase acute and latent herpes simplex virus type 2 latency-associated transcript expression but do not influence recurrence phenotype or establishment of latency. J. Virol. 70:1535-1541.
326. Youssoufian, H., S. M. Hammer, M. S. Hirsch, and C. Mulder. 1982. Methylation of the viral genome in an in vitro model of herpes simplex virus latency. Proc. Natl. Acad. Sci. USA 79:2207-2210.
327. Yuhasz, S. A., and J. G. Stevens. 1993. Glycoprotein B is a specific determinant of herpes simplex virus type 1 neuroinvasiveness. J. Virol. 67:5948-5954.
328. Zhu, Z., W. Cai, and P. A. Schaffer. 1994. Cooperativity among herpes simplex virus type 1 immediate-early regulatory proteins: ICP4 and ICP27 affect the intracellular localization of ICP0. J. Virol. 68:3027-3040.
329. Ziegler, R. J., and R. E. Herman. 1980. Peripheral infection in culture of rat sensory neurons by herpes simplex virus. Infect. Immun. 28:620-623.
330. Zwaagstra, J. C., H. Ghiasi, A. B. Nesburn, and S. L. Wechsler. 1989. In vitro promoter activity associated with the latency-associated transcript gene of herpes simplex virus type 1. J. Gen. Virol. 70:2163-2169.
331. Zwaagstra, J. C., H. Ghiasi, A. B. Nesburn, and S. L. Wechsler. 1991. Identification of a major regulatory sequence in the latency associated transcript (LAT) promoter of herpes simplex virus type 1 (HSV-1). Virology 182:287-297.
332. Zwaagstra, J. C., H. Ghiasi, S. M. Slanina, A. B. Nesburn, S. C. Wheatley, K. Lillycrop, J. Wood, D. S. Latchman, K. Patel, and S. L. Wechsler. 1990. Activity of herpes simplex virus type 1 latency-associated transcript (LAT) promoter in neuron-derived cells: evidence for neuron specificity and for a large LAT transcript. J. Virol. 64:5019-5028.